**Question:** As compared to unfractionated heparin, low molecular weight heparin -

A. has a shorter half-life
B. requires higher doses
C. has a narrower therapeutic index
D. has a lower risk of bleeding

**Core Concept:** Heparins are anticoagulants used to prevent and treat thromboembolic events. Unfractionated heparin (UFH) and low molecular weight heparin (LMWH) are both types of heparins, but they differ in their molecular structure and pharmacokinetic properties.

**Why the Correct Answer is Right:** Low molecular weight heparins, such as enoxaparin, dalteparin, and tinzaparin, are chemically modified versions of UFH. They have a shorter molecular weight, which leads to a few advantages:

1. **Shorter half-life:** LMWH has a more rapid onset and offset of action compared to UFH. This allows for less frequent administration, making LMWH more convenient for patients and healthcare providers.
2. **Lower risk of bleeding:** Due to their shorter half-life, LMWH has a reduced risk of bleeding when compared to UFH. This is because UFH has a longer half-life, which increases the risk of bleeding when administering it subcutaneously (SC).

**Why Each Wrong Option is Incorrect:**

A. **Higher doses required:** While it is true that LMWH needs a dose adjustment based on renal function, it does not require higher doses overall when compared to UFH. The correct answer is not "higher doses," but rather a "shorter half-life."

B. **Wider therapeutic index:** This statement is incorrect since both UFH and LMWH have similar therapeutic indices. The correct focus should be on the shorter half-life and lower bleeding risk of LMWH.

**Clinical Pearl:** When selecting between UFH and LMWH, consider factors like patient preference, renal function, and treatment duration. LMWH has advantages in terms of convenience, lower bleeding risk, and easier dose adjustment. However, UFH may be preferred in certain cases, such as patients with severe renal impairment or when a rapid anticoagulant effect is required. Consult the patient's clinical context and individual circumstances to select the appropriate anticoagulant therapy.